Skip to content

Journal of Vision

ISSN 1534-7362

4 papers in the library · 15 citations · publishing 2010-2024

Papers

Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors

Journal of Vision March 17, 2010 Olivia Carter, David C. Burr, John D. Pettigrew et al. 6 citations

A hallucinogenic drug that activates serotonin receptors, psilocybin, impairs the ability to track multiple moving objects but does not affect spatial working memory, indicating a functional separation between these two cognitive processes. Blocking one type of serotonin receptor (5-HT2A) with ketanserin did not prevent this attentional deficit, pointing to the involvement of another receptor (5-HT1A) instead. The impairment may stem from difficulty ignoring distractions rather than a reduction in attentional capacity itself.

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion

Journal of Vision September 1, 2016 Leor Roseman, Martin I. Sereno, Robert Leech et al. 4 citations

Under LSD, the visual cortex's resting-state functional connectivity (RSFC) becomes more dependent on its intrinsic retinotopic organization, as if the brain were processing actual visual input despite closed eyes. In 10 healthy subjects, RSFC between non-adjacent patches of V1 and V3 that represent congruent parts of the visual field (both horizontal or both vertical meridians) was significantly stronger than connectivity between incongruent patches (horizontal-vertical), compared to placebo. The difference between congruent and incongruent connectivity was greater under LSD (Cohen's d=1.6), suggesting that psychedelic imagery involves transient local retinotopic activation similar to that from visual stimulation.

Psilocybin slows binocular rivalry switching through serotonin modulation

Journal of Vision March 19, 2010 O. Carter, John D. Pettigrew, Felix Hasler et al. 3 citations

Binocular rivalry, the fluctuation in visual awareness when different images are shown to each eye, is slowed by the hallucinogenic compound psilocybin, the active ingredient in magic mushrooms. In ten healthy human subjects, psilocybin reduced the rate of switching between percepts and increased the experience of mixed or transitional percepts. Pretreatment with ketanserin, a selective 5-HT2A receptor antagonist, blocked most of psilocybin's positive psychotic-like symptoms but did not affect the slowing of binocular rivalry switching or negative symptoms related to reduced arousal and vigilance. This suggests that the slowing of binocular rivalry by psilocybin is not mediated by 5-HT2A receptors but may instead involve 5-HT1A receptor activation reducing serotonin release from the brainstem raphe nuclei, linking rivalry switching rate to arousal and attention.

Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial

Journal of Vision November 5, 2024 Sophia Jungers, Ranji Varghese, Link Swanson et al. 2 citations

A small experiment with six participants tested whether the psychedelic compound psilocybin alters surround suppression, a visual effect where a high-contrast background reduces the perceived contrast of a central object. After taking 25 mg of psilocybin, participants reported stronger surround suppression compared to placebo (100 mg niacin). The intensity of subjective psychedelic visuals correlated positively with the magnitude of surround suppression. No serious adverse events occurred. The findings suggest a link between serotonergic neuromodulation and visual contrast perception, and may relate to weakened surround suppression observed in major depressive disorder and schizophrenia.